Back to search results

Proton or Photon RT for Retroperitoneal Sarcomas

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Retroperitoneal Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Rush University Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Dian Wang, MD) · dian_wang@rush.edu

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Thomas DeLaney, MD) · tdelaney@partners.org · 6177266876
    Contact: Principal Investigator (Thomas DeLaney, MD)

  • Dana-Farber Cancer Institute, Boston, Massachusetts, United States

    Contact: Study coordinator (Elizabeth Baldini, MD, MPH) · ebaldini@partners.org · 6177326310
    Contact: Principal Investigator (Elizabeth Baldini, MD, MPH)

  • Mayo Clinic, Rochester, Minnesota, United States

    Contact: Study coordinator (Ivy Peterson, MD) · petersen.ivy@mayo.edu

  • Washington University School of Medicine Siteman Cancer Center West County, Creve Coeur, Missouri, United States

    Contact: Study coordinator (Jeff Michalski, MD) · jmichalski@radonc.wustl.edu

  • Washington University School of Medicine Siteman Cancer Center South County, St Louis, Missouri, United States

    Contact: Study coordinator (Jeff Michalski, MD) · jmichalski@radonc.wustl.edu

  • Roswell Park Cancer Institute, Buffalo, New York, United States

    Contact: Study coordinator (Varun Chowdhry, MD) · mailto:Varun.Chowdhry@RoswellPark.org
    Contact: Principal Investigator (Varun Chowdhry, MD)

  • Duke University, Durham, North Carolina, United States

    Contact: Study coordinator (Trey Blazer, MD) · trey.blazer@duke.edu

  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Andrew Bishop, MD)
    Contact: Principal Investigator (Andrew Bishop, MD)

  • University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Ying Hitchcock, MD) · ying.hitchcock@hci.utah.edu
Study leads

  • Thomas F. DeLaney, M.D.

    Principal Investigator

    Massachusetts General Hospital

View source on ClinicalTrials.gov(opens in a new tab)